Analysis on the Characteristics and Prognosis of Pulmonary Neuroendocrine Tumors |
Wu, Bai-Shou
(First Department of Medical Oncology, Chinese PLA General Hospital)
Hu, Yi (First Department of Medical Oncology, Chinese PLA General Hospital) Sun, Jing (First Department of Medical Oncology, Chinese PLA General Hospital) Wang, Jin-Liang (First Department of Medical Oncology, Chinese PLA General Hospital) Wang, Peng (First Department of Medical Oncology, Chinese PLA General Hospital) Dong, Wei-Wei (First Department of Medical Oncology, Chinese PLA General Hospital) Tao, Hai-Tao (First Department of Medical Oncology, Chinese PLA General Hospital) Gao, Wen-Juan (First Department of Medical Oncology, Chinese PLA General Hospital) |
1 | Thomas CF Jr, Tazelaar HD, Jett JR (2001). Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest, 119, 1143-50. DOI ScienceOn |
2 | Yucel B, Babacan NA, Kacan T, et al (2013). Survival analysis and prognostic factors for neuroendocrine tumors in Turkey. Asian Pac J Cancer Prev, 14, 6687-92. 과학기술학회마을 DOI ScienceOn |
3 | Zeng YJ, Liu L, Wu H, et al (2013). Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution. Asian Pac J Cancer Prev, 14, 5775-81. 과학기술학회마을 DOI ScienceOn |
4 | Naalsund A, Rostad H, Strom EH, et al (2011). Carcinoid lung tumors-incidence, treatment and outcomes: a populationbased study. Eur J Cardiothorac Surg, 39, 565-9. DOI ScienceOn |
5 | Rekhtman N (2010). Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med, 134, 1628-38. |
6 | Travis WD (2010). Advances in neuroendocrine lung tumors. Ann Oncol, 21, 65-71. DOI ScienceOn |
7 | Travis WD, Brambilla E, Muller-Hermelink HK, et al (2004). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: I-ARC Press: World Health Organization Classification of Tumours, 10. |
8 | Travis WD, Giroux DJ, Chansky K, et al (2008). The IASLC Lung Cancer Staging Project: Proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol, 3, 1213-23. DOI ScienceOn |
9 | Travis WD, Rush W, Flieder DB, et al (1998). Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol, 22, 934-44. DOI ScienceOn |
10 | Vallieres E, Shepherd FA, Crowley J, et al (2009). The IASLC Lung Cancer Staging Project: Proposals regarding the relevance of TNM in the pathologic staging of SCLC in the forthcoming (seventh) edition if the TNM classification for lung cancer. J Thorac Oncol, 4, 1049-59. DOI ScienceOn |
11 | Yeh YC, Chou TY (2014). Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses. J Surg Oncol, 109, 280-6. DOI ScienceOn |
12 | Lim E, Yap YK, De Stavola BL, et al (2005). The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors. J Thorac Cardiovasc Surg, 130, 969-72. DOI ScienceOn |
13 | Liu SZ, Zhang F, Chang YX, et al (2013). Prognostic impact of cyclin D1, cyclin E and P53 on gastroenteropancreatic neuroendocrine tumours. Asian Pac J Cancer Prev, 14, 419-22. 과학기술학회마을 DOI ScienceOn |
14 | Garcia-Yuste M, Matilla JM, Alvarez-Gago T, et al (2000). Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNESEPAR). Ann Thorac Surg, 70, 258-63. DOI ScienceOn |
15 | Gridelli C1, Rossi A, Airoma G, et al (2013). Treatment of pulmonary neuroendocrine tumours: state of the art and future developments. Cancer Treat Rev, 39, 466-72. DOI ScienceOn |
16 | Haghighi S, Molaei M, Foroughi F, et al (2012). Role of endoscopic ultrasound in evaluation of pancreatic neuroendocrine tumors--report of 22 cases from a tertiary center in Iran. Asian Pac J Cancer Prev, 13, 4537-40. 과학기술학회마을 DOI ScienceOn |
17 | Lyoda A, Hiroshima K, Nakatani Y, et al (2007). Pulmonary LCNEC: its place in the spectrum of pulmonary carcinoma. Ann Thorac Surg, 84, 702-7. DOI ScienceOn |
18 | Massard G, Ducrocq X, Kochetkova EA, et al (2006). Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study. Eur J Cardiothorac Surg, 30, 164-7. DOI ScienceOn |
19 | McCaughan BC, Martini N, Bains MS (1985). Bronchial carcinoids: review of 124 cases. J Thorac Cardiovasc Surg, 89, 8-17. |
20 | Merrill RM, Henson DE, Barnes M (1999). Conditional survival among patients with carcinoma of the lung. Chest, 116, 697-703. DOI ScienceOn |
21 | Chong S, Lee KS, Chung MJ, et al (2006). Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radio Graphics, 134, 41-57. |
22 | Costes V, Marty-Ane C, Picot MC, et al (1995). Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study. Hum Pathol, 26, 740-5. DOI ScienceOn |
23 | Cardillo G, Sera F, Di Martino M, et al (2004). Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac surg, 77, 1781-5. DOI ScienceOn |
24 | Carretta A, Ceresoli GL, Arrigoni G, et al (2000). Diagnostic and therapeutic management of neuroendocrine lung tumors: a clinical study of 44 cases. Lung Cancer, 29, 217-25. |
25 | Detterbeck FC (2010). Management of carcinoid tumors. Ann Thorac Surg, 89, 998-1005. DOI ScienceOn |
26 | Edge SB, Byrd DR, Compton CC, et al (2010). AJCC Cancer Staging Manual. NEW York: Springer. |
27 | Ferguson MK, Landreneau RJ, Hazelrigg SR, et al (2000). Longterm outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg, 18, 156-61. DOI ScienceOn |
28 | Ferolla P, Daddi N, Urbani M, et al (2009). Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchialcarcinoids. Thorac Oncol, 4, 383-7. DOI ScienceOn |
29 | Fink G, Krelbaum T, Yellin A, et al (2001). Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review if 640 cases from literature. Chest, 119, 1647-51. DOI ScienceOn |
30 | Filosso PL, Rena O, Donati G, et al (2002). Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg, 123, 303-9. DOI ScienceOn |
31 | Beasley MB, Thunnissen FB, Brambilla E, et al (2000). Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol, 31, 1255-65. DOI ScienceOn |
32 | Filosso PL, Ruffini E, Di Gangi S, et al (2014). Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience. Eur J Cardiothorac Surg, 45, 521-6. DOI |
33 | Asamura H, Kameya T, Matsuno Y, et al (2006). Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol, 24, 70-6. DOI ScienceOn |
34 | Bertino EM, Confer PD, Colonna JE, et al (2009). Pulmonary neuroendocrine/carcinoid tumors: a review article. Cancer, 115, 4434-41. DOI ScienceOn |
35 | Zahir ST, Arjmand A, Kargar S, et al (2013). Incidence and trends of malignant and benign pancreatic lesions in Yazd, Iran between 2001 and 2011. Asian Pac J Cancer Prev, 14, 2631-5. 과학기술학회마을 DOI ScienceOn |
![]() |